SIC 2834 – Pharmaceutical Preparations
| Valuation | |
|---|---|
| Market Cap ($M) | 41.06 |
| Enterprise Value ($M) | 2.40 |
| Book Value ($M) | 17.91 |
| Book Value / Share | 6.86 |
| Price / Book | 2.29 |
| NCAV ($M) | 17.71 |
| NCAV / Share | 6.78 |
| Price / NCAV | 2.32 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | -1.01 |
| Return on Assets (ROA) | -1.66 |
| Return on Equity (ROE) | n/a |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 6.69 |
| Current Ratio | 6.69 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 42.96 |
| Assets | 43.16 |
| Liabilities | 25.25 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 0.00 |
| Operating Income | 0.00 |
| Net Income | 0.00 |
| Earnings Per Share Basic And Diluted | n/a |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | 0.00 |
| Cash from Investing | 0.00 |
| Cash from Financing | 0.00 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13G | Fmr Llc | 7.32 | ||
| 13D/A | MacAndrews & Forbes Inc. | 50.30 | -97.50 | |
| 13D | Baker Bros. Advisors Lp | 4.99 | ||
| 13D | Samsara BioCapital, L.P. | 10.40 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| File Date | Form | SEC Filings |
|---|---|---|
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K | ||
(click for more detail) |
||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 39 | 2,350 | 1.66 | |
| 30 | 5,945 | 0.50 | |
| 6,970 | 13,055 | 53.39 | |
| 629 | 5,325 | 11.81 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| VRPX – Virpax Pharmaceuticals, Inc. | VSTM – Verastem, Inc. |
| VTGN – Vistagen Therapeutics, Inc. | VXRT – Vaxart, Inc. |
| VYNE – VYNE Therapeutics Inc. |
Financial data and stock pages provided by
Fintel.io